ABIN-MEDIATED PROTECTION AGAINST LUNG INFLAMMATORY DISEASE
摘要
<p>The present invention relates to the treatment of airway inflammation. Specifically, the airway inflammations which form the subject of the present invention are mediated by the transcription factor NF-?B. The treatment comprises the use of A20-binding inhibitors of NF-B activation (ABINs). The A20-binding inhibitors of NF-?B activation (ABINs) of the present invention are used in the preparation of a medicament for treating airway inflammation. The airway inflammations of the present invention include asthma and chronic obstructive pulmonary disease (COPD).</p>
